The generation of research-quality, clinically relevant cell types in vitro from human pluripotent stem cells requires a detailed understanding of the equivalent human cell types. Here we analysed 134 human embryonic and fetal samples from 6 to 20 developmental weeks and identified the stages at which cKIT + primordial germ cells (PGCs), the precursors of gametes, undergo whole-genome epigenetic reprogramming with global depletion of 5mC, H3K27me3 and H2A.Z, and the time at which imprint erasure is initiated and 5hmC is present. Using five alternative in vitro differentiation strategies combined with single-cell microfluidic analysis and a bona fide human cKIT + PGC signature, we show the stage of cKIT + PGC formation in the first 16 days of differentiation. Taken together, our study creates a resource of human germ line ontogeny that is essential for future studies aimed at in vitro differentiation and unveiling the mechanisms necessary to pass human DNA from one generation to the next.
before this can be achieved, the major landmarks of human germ line development during embryonic and fetal life must be characterized.
Human germ line development begins with the formation of PGCs that express the tyrosine kinase receptor cKIT (refs 4-10) . Very little is known about the developmental progression (ontogeny) of cKIT + PGCs; however, on the basis of the mouse model, it is clear that PGCs must undergo whole-genome epigenetic reprogramming to remove cytosine methylation from imprinted genes and restore totipotency [11] [12] [13] [14] . Given the fundamental role of epigenetic reprogramming in the germ line, it is essential to characterize reprogramming in human PGCs because mouse and human genomes are separated by ∼170 million years and diverse strategies may have evolved to execute it. Once the major molecular landmarks of human PGC reprogramming are known, we propose that this information will be critical to assessing PGC differentiation and reprogramming in vitro, or identifying bottlenecks that must be overcome to generate a functional germ line from hPSCs.
By evaluating 134 human embryonic and fetal gonadal samples from 6 to 20 developmental weeks, we provide the first comprehensive tran- In testes, n = 9 optic fields were counted at 7-11 wk (collected from 5 samples), n = 9 optic fields at 12.5-14 wk (3 samples) and n = 7 optic fields at 16-17 wk (2 samples). (d) In ovaries, n = 7 optic fields were counted at 7-9.5 wk (4 samples), n = 8 optic fields at 11-14 wk (3 samples) and n = 7 optic fields at 18-19 wk (3 samples). (e,f) Representative immunofluorescence micrographs of cKIT with OCT4A at the developmental weeks indicated. (e) A 10-week testis for 7-10.5 wk (5 samples), a 13.5-week testis for 11-16.5 wk (4 samples) and a 17-week testis (1 sample). Arrowhead indicates a cKIT + OCT4A-negative cell. (f) An 8-week ovary for 6-8.5 wk (3 samples), an 11-week ovary for 9.5-14 wk (3 samples) and an 18-week ovary for 16.5-18 wk (2 samples). (g,h) Quantification of nuclear or cytoplasmic localization of OCT4A in cKIT + cells. (g) In testes, n = 6 optic fields were counted at 7-10.5 wk (5 samples), n = 8 optic fields at 11-16.5 wk (4 samples) and n = 6 optic fields at 17 wk (1 sample). (h) In ovaries, n = 6 optic fields were counted at 7-8.5 wk (3 samples), n = 8 optic fields at 9.5-14 wk (3 samples) and n = 9 optic fields at 16.5-18 wk (2 samples). For immunofluorescence microscopy, nuclei were counterstained with DAPI (blue); scale bars, 10 µm. For quantification, on average 40 cells per optic field were counted using a 40× objective. All data are expressed as mean ± s.e.m. of n = total number of optic fields per age group as indicated. Wk (wk), week; N/E, not expressed.
scriptional and epigenetic roadmap of human cKIT + PGCs in testes and ovaries and pinpoint the timing of major epigenetic events including whole-genome reprogramming and initiation of imprint erasure. Using the endogenous human cKIT + PGCs as a reference, we can now more accurately interpret the identity of the cKIT + subpopulation of PGCs acquired with in vitro differentiation from hESCs. Our results clearly demonstrate that single-cell analysis at both RNA and protein level is critical to defining PGC identity in vitro, and indisputably shows that established hESC lines are not equivalent to human PGCs.
RESULTS

cKIT + PGCs undergo molecular progression with fetal development
Temporal and spatial expression of cKIT in fetal testes and ovaries from 7 to 19 weeks of development was evaluated by immunofluorescence microscopy together with the evolutionarily conserved germ cell marker VASA. All testes samples procured had characteristic seminiferous cords by histology, indicating that sex determination had been initiated 15 ( Supplementary Fig. S1 ). We identified cKIT on the surface of all VASA + cells in testes from 7 to 11 weeks and ovaries from 7 to 9.5 weeks (Fig. 1a,b and Supplementary Fig. S2a ). However, from 12.5 weeks in testes, and 11 weeks in ovaries, cKIT and VASA protein expression becomes uncoupled, with only 10% of cKIT + cells co-expressing VASA (arrows in Fig. 1a ,b, quantified in Fig. 1c,d and Supplementary Fig. S2b ). On uncoupling, the ratio of single cKIT + to single VASA + cells was 1:1. We also evaluated SSEA1, and found that although PGCs are SSEA1 + in fetal testes at the 'common PGC progenitor stage' and after cKIT/VASA uncoupling, SSEA1 alone is not specific for the human germ line because it was also expressed on cKITand VASA-negative cells (not germ cells; Supplementary Fig. S3a,b) . 
and SYCP3 (S) in triplicate (columns) in 100, 50, 10, 0 or single sorted cKIT + cells (rows).
To assess the stem cell identity of cKIT + gonadal cells we examined the germ/stem-cell-enriched protein OCT4A using antibodies against the amino-terminal region that discriminates OCT4A from the splice variant OCT4B (refs 16,17; Fig. 1e,f) . OCT4A localized to the nucleus of cKIT + cells from 7 to 10.5 weeks in testes and 6-8.5 weeks in ovaries (just before VASA repression). Similarly, expression of the pluripotency marker TRA-1-81 highly correlated with nuclear OCT4A in both sexes ( Supplementary Fig. S3c,d ). After this time, our data indicate that OCT4A + cells become a subpopulation of cKIT + , and most cKIT + PGCs localize OCT4A protein to the cytoplasm. In addition, a number of cKIT + cells no longer express OCT4A (Fig. 1g,h ). At 17 weeks in fetal testes and from 16.5 weeks in fetal ovaries, OCT4A is again identified in the nucleus of a large fraction of cKIT + cells (Fig. 1g,h ). Therefore, using cKIT, OCT4A and VASA expression, we propose a common PGC progenitor stage in humans that lasts to 11 weeks in testes and 9.5 weeks in ovaries. Thereafter two major populations are established in males and females, the cKIT + population that expresses OCT4A in most cells, and the single VASA Table S1 ), using the gating strategy shown in Fig. 2a,b . Applying this sorting strategy on a 15.5-week testis, in combination with quantitative PCR with reverse transcription (qRT-PCR), we verified that germ line identity was specifically enriched in the cKIT bright fraction compared with cKIT dim or single SSEA1-expressing cells ( Supplementary Fig. S4a-c) . We speculate that the cKIT dim gate is a heterogeneous mixture of PGCs and non-PGCs given that all germ line genes including VASA are reduced relative to the cKIT bright fraction. Therefore, to avoid potential contamination with gonadal somatic cells in downstream applications, we excluded cKIT dim cells from all future FACS. Using the cKIT bright gate (which we call cKIT + ) we sorted an average of 2.83% cKIT + cells per testis at 8-11 weeks and 2.45% cKIT + cells per ovary at 8-9.5 weeks. Then at 11.1-20 weeks we sorted an average of 0.9% cKIT + cells from individual testes and 4.75% cKIT + cells per ovary at 9.6-16.5 weeks (Fig. 2a,b) . The absolute number of cKIT + cells sorted from an individual testis was as low as 150 for a 20-week sample, with most samples yielding 2,500-3,000 cKIT + cells per testis. Similarly, fetal ovaries yielded on average 4,500-5,000 cells per ovary, ranging from as low as 276 cells for an 8-week ovary to 30,000 cells for a 16.5-week ovary. This range in absolute numbers most likely reflects variability in sample quality (intact gonads versus fragments) and viability (which ranged from 14.4% to 64.7%). However, the variability in the percentage of cKIT + cells in the ovary did not correlate with overall sample viability, and instead we speculate that this variability was due to the presence of small amounts of attached non-gonadal tissue that varied from sample to sample.
To determine the molecular identity of cKIT + PGCs, we performed single-cell analysis with five PGC signature genes including OCT4, BLIMP1, DAZL, VASA and NANOS3 using FACS, followed by microfluidic qRT-PCR at the common progenitor and cKIT/VASA uncoupled stage (Fig. 2c-g ). We also confirmed expression of cKIT in individual cells (Fig. 2f) . Our single-cell approach was first validated in HEK293T cells ( Supplementary Fig. S4e-h ). At the common PGC progenitor stage, 14/16 cKIT + cells in the testis and 13/20 cKIT + cells in the ovary coordinately expressed the five PGC signature genes (Fig. 2c,d ). However, in the ovary 7/20 cKIT + cells did not express VASA and/or DAZL at this stage and instead were OCT4/BLIMP1 double positive (O/B) or OCT4/BLIMP1/NANOS3 triple positive (O/B/N3). In testes, NANOS2 expression was also evaluated and found in <20% of cKIT + cells in the common progenitor and this was maintained on cKIT/VASA uncoupling in the cKIT + cell (Fig. 2c,e) . In the ovary during the uncoupled stage when OCT4A is either in the cytoplasm or no longer expressed, NANOS3 messenger RNA is also no longer expressed in a fraction of cells, and these NANOS3-negative cells correlated with no or low levels of OCT4 and BLIMP1 (Fig. 2f) . At 16.5 weeks, when OCT4A is again localized to the nucleus or not expressed, ovarian cKIT + cells become even more (g) CGRA of the PEG3 DMR showing the percentage of total methylation (5mC + 5hmC) or 5hmC alone, relative to total amplified DNA (uncut) at the PEG3 DMR. DNA from BJ fibroblast and H1 hESCs was used as a negative control (for each, n = 2 biological replicates). For immunofluorescence microscopy analysis, nuclei were counterstained with DAPI (blue). Scale bars, 10 µm. All data are represented as mean ± s.e.m. N/A, not amplified; wk, week.
heterogeneous, most notably involving loss of NANOS3, OCT4 and BLIMP1 mRNA in some cells, with DAZL and VASA being absent in others (Fig. 2g) . SYCP3 was used to indicate meiotic potential, and was expressed in every cell at 14 and 16.5 weeks (Fig. 2f,g ). Furthermore, at 16.5 weeks, SYCP3 and VASA mRNA expression levels were significantly enriched in the NANOS3-negative population ( Supplementary Fig. S4d ). Despite SYCP3 mRNA expression in every cell at a single-cell level, on the protein level, only VASA + cells are immunopositive for SYCP3 in the fetal ovary from 14 weeks and not cKIT + ( Supplementary Fig. S3e ), indicating that VASA + cells are the first to acquire meiotic potential.
Loss of 5mC from imprinted DMRs is locus specific and occurs weeks after global 5mC depletion
By immunofluorescence microscopy, 5-methyl cytosine (5mC) was below the level of detection at all stages of PGC development compared with somatic cells (open arrowheads on Fig. 3a,b) . To evaluate cytosine methylation at differentially methylated regions (DMRs) of imprinting control centres, we used bisulphite sequencing (BS) followed by PCR (BS-PCR) on cKIT + -sorted PGCs (Fig. 3c,d ). We evaluated two paternally methylated DMRs, H19 and MEG3, and two maternally methylated DMRs, PEG3 and KCNQ1. Primers were first verified using the BJ primary fibroblast cell line and H1 hESCs ( Supplementary  Fig. S5a ). For the paternally methylated H19 and MEG3 DMRs, we observed CpG methylation at all developmental ages in male cKIT + PGCs. In contrast, maternally methylated DMRs in the testis exhibited a sharp reduction in CpG methylation between 16 and 17 weeks, and for KCNQ1, methylation was completely lost in the one 20-week sample consented to our study. Analysis of the ovary revealed a significant reduction of CpG methylation by 16.5 weeks at all loci. At paternally methylated DMRs, erasure was complete by 14.5-15 weeks for H19, and near complete by 16.5 weeks for MEG3. (c) In testes for quantification in OCT4A + , n = 6 optic fields were counted at 7-10.5 wk (collected from 3 samples), n = 14 optic fields at 11-16.5 wk (7 samples) and n = 6 optic fields at 17 wk (1 sample). For quantification in VASA + , n = 6 optic fields were counted at 7-10.5 wk (3 samples), n = 10 optic fields at 11-16.5 wk (7 samples) and n = 6 optic fields at 17 wk (1 sample). (d) In ovaries, for quantification in OCT4A + , n = 6 optic fields were counted at 6-8.5 wk (3 samples), n = 10 optic fields at 9.5-14 wk (4 samples) and n = 8 optic fields at 16.5-18 wk (3 samples). For quantification in VASA + , n = 4 optic fields were counted at 6-8.5 wk (3 samples), n = 10 optic fields at 9.5-14 wk (4 samples) and n = 7 optic fields at 16.5-18 wk (3 samples). (e,f) Representative immunofluorescence micrographs of H2A.Z with VASA in testes from 7 to 9 weeks (e), and ovary at 7.5 weeks (f). (e) A 9-week testis for 7-9 wk (n = 2). (f) A 7.5-week ovary (n = 2). For immunofluorescence microscopy, nuclei were counterstained with DAPI (blue). Scale bars, 10 µm. For quantification, on average 40 cells per optic field were counted using a 40× objective. All data are expressed as mean±s.e.m. of n = total number of optic fields per age group as indicated. Wk (wk), week.
5hmC is the major methylation species in the common PGC progenitor and is localized to the PEG3 DMR before demethylation Immunofluorescence microscopy for 5hmC, the oxidized derivative of 5mC, revealed robust nuclear staining in somatic cells at all time points (open arrowheads in Fig. 3e,f) , similar to previous reports in the mouse 18 . However, in the germ line, 5hmC expression is dynamic, exhibiting punctate nuclear staining in the common PGC progenitor stage (arrows on Fig. 3e,f) , which is lost in OCT4A + PGCs in the testis from 13.5 to 16 weeks (Fig. 3e) . Enrichment of 5hmC is again detected in some OCT4A
+ PGCs by 17 weeks (Fig. 3e) . In fetal ovaries, 5hmC is heterogeneous at 11-19 weeks, being enriched in some but not all OCT4A + cells (Fig. 3f) . Bisulphite conversion does not distinguish between 5mC and 5hmC; therefore, we used combined glycosylation restriction analysis (CGRA) at the PEG3 DMR to identify whether 5hmC is enriched at this imprinted locus in PGCs relative to somatic cells or hESCs (Fig. 3g) . We identified the glycosylated product of 5hmC (5ghmC) at all stages of PGC development in both sexes at the PEG3 DMR. In contrast, 5ghmC was not enriched at the PEG3 locus in BJ and H1 cells. 
H3K27me3 and H2A.Z are enriched in common PGC progenitor cells
In the mouse, gonadal epigenetic reprogramming of PGCs and imprint erasure occurs from embryonic day (E)11.5 to E12.5 coincident with global changes in chromatin, including a transient loss of tri-methylation of Lys 27 on histone H3 (H3K27me3) and a permanent loss of the histone variant H2A.Z (ref. 12). In humans, using immunofluorescence microscopy we show that H3K27me3 is enriched in the nucleus of common PGC progenitors in testes from 7 to 10.5 weeks (Fig. 4a,c) . However, at 11 weeks, the endpoint of the common progenitor stage, H3K27me3 is at or below the level of detection in most OCT4A + and VASA + PGCs (Fig. 4a,c) . Interestingly, at 17 weeks in testes, H3K27me3 is again observed in the nucleus of ∼38% OCT4A + and VASA + PGCs. In ovaries, H3K27me3 is absent in 50-60% of common PGC progenitors at 6-8.5 weeks (Fig. 4b,d ), after which all PGCs are negative for H3K27me3 (Fig. 4b,d) . Similarly, H2A.Z is enriched in the nucleus of common-progenitor-stage PGCs at 7-9 weeks in the testis and 7.5 weeks in the ovary (Fig. 4e,f) . However, at the end of the common progenitor stage all PGCs become devoid of H2A.Z until around 17 weeks when H2A.Z reappears in the nucleus of a few VASA + cells in both sexes ( Supplementary Fig. S5b,c) .
RNA-Seq reveals that cKIT + PGCs are transcriptionally distinct from hESCs
To generate a comprehensive portrait of cKIT + PGCs in the fetal testis and ovary, we performed RNA-Sequencing (RNA-Seq) of cKIT + PGCs sorted at 16-16.5 weeks from fetal testes (n = 2), fetal ovaries (n = 2) and H1 hESCs sorted with the pluripotent marker TRA-1-60 (n = 3). At this developmental time point, male cKIT + PGCs are initiating imprint erasure, whereas in females some imprinted loci show near complete demethylation (H19 and MEG3). A heat map of the 5,455 differentially expressed genes in at least one of three pair-wise comparisons is shown in Fig. 5a . Pearson correlation coefficient analysis showed strong correlations between biological replicates in each group (Fig. 5b) . Gene Ontology (GO) analysis of the 13 differentially expressed gene clusters revealed that male and female cKIT + PGCs are enriched in GO terms including negative transcription regulation, sex differentiation, and in females, meiosis and germ plasm when compared with hESCs. In contrast, hESCs are enriched in GO terms related to macromolecule biosynthetic processing, RNA processing/splicing and mitosis (Fig. 5a ). Comparing testicular and ovarian cKIT + PGCs revealed 433 differentially expressed genes, with GO terms such as meiosis, oocyte development and DNA repair. In females, this included enrichment in DAZL, VASA, ZP3 and STRA8, and in males, NANOS2 and NANOS3 (Fig. 5c) .
Given that 5hmC was detected at 16-16.5 weeks by either CGRA and/or immunofluorescence microscopy in cKIT + PGCs, we also examined the expression of the ten-eleven translocation (TET ) genes, which are responsible for converting 5mC to 5hmC (refs 19-21; Fig. 5c ). All three TET family members (TET1-3) are expressed by male and female PGCs, with a significant enrichment of TET2, and reduced expression of TET1 relative to H1 hESCs. We also evaluated the DNA methyltransferases (DNMTs) DNMT1, DNMT3A, DNMT3B and DNMT3L. Male but not female PGCs exhibited a significant decrease in DNMT1 relative to H1 hESCs. Furthermore, all PGC samples had reduced levels of expression of DNMT3A and DNMT3B relative to H1. AICDA (also known as AID) and TDG were expressed at variable levels in H1 and also in PGCs of both sexes. cKIT/TRA-1-81-positive PGCs generated in vitro correspond to immature pre-gonadal PGCs We next sought to generate cKIT + PGCs in vitro from H1 (XY) and UCLA1 (XX) hESCs (refs 22,23) . In our sorting strategy we incorporated TRA-1-81, as the second marker with cKIT, on the basis of the high OCT4/TRA-1-81 correlation in the human gonad before ten developmental weeks (Supplementary Fig. S3d ). Given that undifferentiated hESCs expressed detectable levels of germ line genes by RNA-Seq similar to previously reported 24, 25 , we performed single-cell analysis of sorted TRA-1-60 + hESCs (Fig. 5d,e) and TRA-1-81 + /cKIT + hESCs (Fig. 5f,g ). As expected, analysis of 100 pooled undifferentiated hESCs resulted in the identification of 5/5 or 3/4 PGC signature genes together with OCT4. However, interrogation at a single-cell level revealed that the major PGC determinant BLIMP1 (ref. 26 ) was rarely expressed, and most PGC signature genes were seldom co-expressed in single cells regardless of sorting strategy. Next, PGC differentiation was evaluated for up to 16 days by serum-induced differentiation of hESCs: as embryoid bodies with, and without, BMP4 addition; adherent monolayer differentiation on growth-factor-reduced matrigel (GFR M/G); differentiation on human fetal gonadal stromal cells (hFGSC); and a combination of embryoid body differentiation, followed by plating embryoid bodies on hFGSCs (Figs 6 and 7) . First we verified that TRA-1-81 faithfully reports OCT4 expression on hESC differentiation for 28 days by flow cytometry using the H1 OCT4-GFP line created by homologous recombination 27 ( Fig. 6a,b) . Using the gating strategy shown in Fig. 6c (H1 day-9 embryoid bodies), we sorted the brightest TRA-1-81 + /cKIT + cells on in vitro differentiation averaging 0.3% of the live population, with no significant difference in the percentage of positive cells when comparing differentiation strategy or length of time in differentiation. Our data show that >97% of TRA-1-81 + /cKIT + differentiated cells are negative for CD45, excluding the possibility of contamination with cKIT + haematopoietic progenitors 28 (Fig. 6c) . Single-cell analysis of cKIT + /TRA-1-81 + cells sorted from embryoid bodies at day 9 revealed a significant increase in the proportion of cells expressing BLIMP1 (Fig. 6d) . We show that the identity of putative PGCs was heterogeneous being either O/B double positive, or O/B/N3 triple positive with no co-expression of DAZL or VASA (Figs 6d and 7c) . Although rare O/B and O/B/N3 single cells were identified in the undifferentiated state ( Fig. 5d-f) , differentiation resulted in a clear enrichment for both O/B and O/B/N3 cell types. In particular, embryoid body differentiation for 9 days yielded 9-fold enrichment in O/B and 7.5-fold enrichment in O/B/N3 cells relative to cKIT + /TRA-1-81 + self-renewing hESCs (quantified in Fig. 7a,b) . Immunofluorescence microscopy of day-9 embryoid bodies verified that cKIT + cells co-expressed OCT4A, exhibited nuclear localization of BLIMP1 and expressed NANOS3 in the cytoplasm, sim- 
triple-positive cells ilar to what is observed in cKIT + PGCs from the human fetus (Fig. 6e ,f and Supplementary Fig. S3c ). Immunofluorescence microscopy also revealed that all NANOS3/OCT4A + cells in the day-9 embryoid body were positive for 5mC (Fig. 6e) . Taken together, our data suggest that TRA-1-81 + /cKIT + /O/B/N3 cells in embryoid bodies correspond to human PGCs before gonadal colonization and loss of 5mC.
Using PGC differentiation in embryoid bodies for 9 days as a comparison, we show that O/B/N3 putative PGCs are transient, being lost by day 15 of embryoid body formation (Fig. 7b,c) . Transferring day-9 embryoid bodies to hFGSCs for a further 7 days (16 days total) was consistent with an increase in survival and/or differentiation of O/B/N3 triple-positive cells; however, DAZL or VASA RNA was not induced in the O/B/N3 population (Fig. 7c) . Sustaining the O/B/N3 triple-positive population within the TRA-1-81 + /cKIT + fraction for 15 days was also achieved using adherent differentiation on GFR M/G (Fig. 7c) .
DISCUSSION
By analysing 134 human embryonic and fetal samples from 6 to 20 developmental weeks and in vitro PGC differentiation from hESCs we propose the following roadmap of human germ line development (Fig. 8) . Our data reveal that the first 16 days of hESC differentiation in vitro, either as embryoid bodies or as monolayers, creates a cKIT + /TRA-1-81 + /OCT4A + PGC population equivalent to a pre-gonadal PGC with 5mC. After reprogramming 1 (denoted by the global depletion of 5mC from the genome followed by enrichment of H3K27me3; ref. 11), we speculate that DAZL and VASA are next expressed, giving rise to the cKIT + /OCT4A + /VASA + common gonadal PGC progenitors that then embark on reprogramming 2 and uncoupling of cKIT expression from VASA. This uncoupling of germ-cell-expressed genes into separate populations was previously reported in second trimester testes and ovaries for OCT4 and VASA protein 29 . Our data are in agreement with cKIT being on the surface of OCT4 + /VASA-negative cells in the fetal gonad 29 . Furthermore, the SYCP3 staining described here also supports the hypothesis that single VASA + germ cells in the ovary are the first to enter the ovarian reserve in fetal life 29 . Our results show that reprogramming 2 in the cKIT + lineage follows a protracted series of events that are similar but not identical to the mouse. This begins with the relatively stable wholesale epigenetic loss of H3K27me3 and H2A.Z in the common progenitor followed by either loss of OCT4A or expression in the cytoplasm. Traditionally, cytoplasmic localization of OCT4 is due to expression of the OCT4B splice variant 16 . Here we used an antibody that discriminates OCT4A from OCT4B (ref. 17) , suggesting that OCT4A in PGCs either translocates to the cytoplasm, or is attenuated there possibly for degradation. The significance of cytoplasmic OCT4A is unknown, but is notably coincident with major global epigenetic changes.
A major event in reprogramming 2 is the erasure of cytosine methylation from DMRs of imprinted genes, which is thought to be active in mice 13 . In the present study we show that 5hmC and the TET enzymes are dynamically expressed by cKIT + human PGCs, as well as other molecular candidates that could actively modify 5mC/5hmC or remove modified 5hmC from the genome, including AICDA and TDG (refs 14,19-21,30,31) . In hESCs and fibroblasts where cytosine methylation at imprinted DMRs is stably inherited, 5hmC is not detected at the PEG3 DMR. In contrast in cKIT + PGCs, where the fate of this locus is demethylation, 5hmC is enriched. Despite this tantalizing correlation, future studies are needed to determine the role of TETs and 5hmC in imprint erasure. One observation from our reference map is that imprint erasure occurs over weeks and in a locus-specific manner. This relatively long window for imprint erasure in cKIT + /cKIT + cells with differentiation does not refute previous findings using DAZL and VASA as markers to define germ line identity 4, 24, [35] [36] [37] [38] [39] [40] [41] . On the contrary, we propose that sorting for TRA-1-81 + /cKIT + specifically enriches for newly specified germ line cells before DAZL and VASA expression and that acquisition of this immature cell can be achieved regardless of differentiation strategy.
We show that accurate interpretation of in vitro differentiation requires not only a detailed understanding of the human counterpart, but also analysis at a single-cell level to confirm molecular identity and rule out stochastic gene expression. In the long term for the field to move forward, functional assays to determine human germ line quality are urgently required. One possibility is using non-human primate hPSCs where transplantation of in vitro derived germ cells is ethically possible. Alternatively, methods for culturing endogenous PGCs in a format that promotes self-renewal and/or differentiation to gonocytes, gonia and meiotic cells rather than EGCs is also needed. The human germ cell lineage is particularly challenging to study owing to the lack of functional assays to test germ cell identity and quality; therefore, the generation of robust molecular maps as described here is the first step to unveiling this important lineage.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Human fetal samples. Fetal testes and ovaries were acquired following elected termination and pathological evaluation for this research programme only after UCLA-IRB review that deemed the project exempt under 45 CRF 46.102(f). Most samples (112) were obtained from the University of Washington Birth Defects Research Laboratory (BDRL), under the regulatory oversight of the University of Washington IRB approved Human Subjects protocol combined with a Certificate of Confidentiality from the Federal Government. BDRL collects the embryonic and fetal tissues (testes and ovaries) and ships them overnight for immediate processing in our laboratory in Los Angeles. In rare cases (21) we obtained de-identified fetal gonads from the UCLA Translational Pathology Core Laboratory and the UCLA Gene and Cellular Core Laboratory (1). All consented material was anonymous and carried no personal identifiers. The BDRL estimates developmental age by prenatal intakes, foot length, Streeter's stage and crown-rump length. Samples with a documented birth defect or chromosomal abnormality were excluded from our study. At UCLA Translational Pathology Core Laboratory and the UCLA Gene and Cellular Core Laboratory, developmental age is calculated by recall of last menstrual period minus 2 weeks. After completing this study we excluded n = 2 fetal testes acquired from UCLA Translational Pathology Core Laboratory that appeared to be older than the developmental age provided after comparing the outcome with the more accurate staging used for the 112 samples acquired from the University of Washington BDRL.
CGRA at the PEG3 DMR. For CGRA analysis at the PEG3 DMR, DNA was extracted using the Quick-gDNA MiniPrep Kit (Zymo Research) according to the manufacturer's instructions. CGRA was next performed using the EpiMark 5hmC and 5mC Analysis Kit (NEB) according to the manufacturer's instructions followed by qRT-PCR for PEG3 DMR DNA using primers PEG3 forward: 5 -CCACCTGCAGCCACTTC-3 and PEG3 reverse: 5 -AGTTGGTTGGGCGAGACAAG-3 with SYBR Green Master Mix (Applied Biosystems) at T m = 65 • C on a Bio-rad MyiQ Thermal Cycler (Bio-rad).
Cell culture. H1 (WA01, 0043, 46XY) and UCLA1 (0058, 46XX) hESC lines were maintained under self-renewal conditions on a mouse embryonic fibroblast layer in Dulbecco's Modified Eagle's Medium (DMEM)/F12 (Gibco BRL), 20% KnockOut Serum (Gibco BRL), 1% non-essential amino acids (NEAA, Gibco BRL), 1 mM l-glutamine (Gibco BRL), 0.1 mM β-mercaptoethanol (Gibco BRL) and 10 ng ml −1 of basic fibroblast growth factor from the Biological Resources Branch of the Frederick National Laboratory for Cancer Research. Undifferentiated hESC colonies were passaged every 7 days and maintained as previously described 4 . For embryoid body differentiation, on day four after passage undifferentiated H1 and UCLA1 cells were treated with collagenase type IV (Gibco BRL; 1 mg ml −1 ) for 45 min at 37 • C. The colonies that dissociated were lifted by gentle pipetting and plated overnight in ultralow attachment 6-well plates (Corning Incorporated) in mTeSR1 medium (StemCell Technologies) supplemented with 10 nM ROCK inhibitor (HA-1077, Sigma-Aldrich). At 24 h after initial plating, the medium was replaced by differentiation medium, DMEM/F12 supplemented with 20% FBS, 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol and 1 mM l-glutamine (all reagents from Gibco BRL). The medium was changed every third day. The addition of 50 ng ml −1 carrier-free BMP4 (R&D Systems) was used where necessary. Adherent differentiation was performed on plates coated with GFR M/G (BD Pharmigen) in differentiation medium, changed every two days. For differentiation on FGSCs, differentiation medium was changed every two days. FGSCs were cultured as previously described 4 . For all experiments, hESCs were used between passages 8 and 45. All hESC experiments were conducted with prior approval from the UCLA Embryonic Stem Cell Research Oversight Committee. BJ fibroblast somatic cells were cultured in minimum essential medium with Earle's salt (Gibco BRL) and 1 mM l-glutamine, 10% FBS (Gibco BRL), 1% NEAA and 1 mM sodium pyruvate (Gibco BRL). HEK293T cells were maintained on gelatin-coated plates in DMEM High Glucose (Gibco BRL) supplemented with 1 mM l-glutamine, 10% FBS (Gibco BRL), 1% NEAA and 1 mM sodium pyruvate (Gibco BRL). BJ and HEK293T cells were passaged using 0.25% trypsin (Gibco BRL) every 5 days.
Differential expression testing. Differential expression analysis was performed using the R package, DESeq and edgeR. Raw read counts were employed and modelled as negative binomial distributed because our data set contains biological replicates. We filtered out lowly expressed genes and transcripts by keeping only those that have at least one count per million in samples. The multiple testing errors were corrected by the false discovery rate. Besides the cutoff as adjusted at P < 0.05, we also adopted another cutoff set as the expression ratio of above twofold changes in expression values. In summary, we considered genes as differentially expressed if: the adjusted P value was less than 0.05; the expression ratio between two conditions was above twofold; there was agreement between DESeq and edgeR. The heat map in Fig. 5c was generated using the default settings with the function 'heatmap.2' in the 'gplots' package of R. RPKM values are centred and scaled by subtracting the mean of the row from every RPKM value and then dividing the resulting RPKM values by the standard deviation of the row.
